ADVFN - ニュース

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/07/31	03 : 52	Business Wire	FDA genehmigt pädiatrische Indikationserweiterung für orale Immuntherapie Palforzia® zur Behandlung von Erdnussallergien in den USA
2024/07/31	03 : 51	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:AIG	American International Group Inc
2024/07/31	03 : 51	PR Newswire (US)	Children's Hospital of Philadelphia Researchers Use AI-Powered Method to Identify Genetic Epilepsies Much Earlier than Genetic Diagnosis
2024/07/31	03 : 50	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/07/31	03 : 50	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/31	03 : 50	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/07/31	03 : 50	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SPFI	South Plains Financial Inc
2024/07/31	03 : 50	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/07/31	03 : 49	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/31	03 : 49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:L	Loews Corporation
2024/07/31	03 : 48	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/31	03 : 48	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/31	03 : 47	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/07/31	03 : 47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ONB	Old National Bancorp
2024/07/31	03 : 47	PR Newswire (US)	PickleRage Welcomes New VP of Franchise Development
2024/07/31	03 : 46	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/07/31	03 : 46	PR Newswire (US)	BGL Announces the Sale of Niles Iron & Metal Company to Charter Manufacturing
2024/07/31	03 : 45	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/07/31	03 : 45	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/07/31	03 : 45	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/31	03 : 45	Business Wire	Engine Capital Nominates Two Highly Qualified Candidates for Election to C&C Group’s Board of Directors
2024/07/31	03 : 45	PR Newswire (US)	Allies Against Slavery Receives Prestigious HHS Grant to Use Data to Prevent and Combat Human Trafficking
2024/07/31	03 : 45	PR Newswire (Canada)	Have Your Say on Regulatory Initiatives
2024/07/31	03 : 44	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/07/31	03 : 44	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/07/31	03 : 44	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:BUKS	Butler National Corp (QX)
2024/07/31	03 : 43	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/07/31	03 : 42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HWBK	Hawthorn Bancshares Inc
2024/07/31	03 : 41	Edgar (US Regulatory)	Form CERT - Certification by an exchange approving securities for listing	AMEX:OSTX	OS Therapies Incorporated
2024/07/31	03 : 41	PR Newswire (US)	Ferrum Health and PaxeraHealth Announce Strategic Partnership to Accelerate Seamless AI Integration in Healthcare

1 2 3 4 5 6 7 8 9 10 次へ >>

Energy Select Sector SPDR

JP Morgan Chase

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約